fondaparinux and its Impurities
Fondaparinux is used to prevent a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs. It is marketed by GlaxoSmithKline. Reference standards of Fondaparinux API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(3S,4S,5S,6R)-6-(((3R,4S,5R,6R)-6-(((3S,4R,5R,6R)-2-Carboxy-4-hydroxy-6-(((3S,4S,5S)-4-hydroxy-5-(hydroxymethyl)-2-((sulfooxy)methyl)tetrahydrofuran-3-yl)oxy)-5-(sulfooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfoamino)-4-(sulfooxy)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3S,4S,5S)-4,5-dihydroxy-3-(sulfoamino)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylic Acid
(3S,4S,5S,6R)-6-(((3R,4S,5R,6R)-6-(((3S,4R,5R,6R)-2-Carboxy-4-hydroxy-6-(((3S,4S,5S)-4-hydroxy-5-(hydroxymethyl)-2-((sulfooxy)methyl)tetrahydrofuran-3-yl)oxy)-5-(sulfooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfoamino)-4-(sulfooxy)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3S,4S,5S)-4,5-dihydroxy-3-(sulfoamino)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylic Acid
Catalogue No.:PA 33 36510
CAS :
NA
Molecular Formula : C30H50N2O46S7
Molecular Weight : 1399.12
